Osteoporosis International · 2021 · 39 citations · 23 references
One-year tofacitinib treatment stabilized BMD in RA patients and resulted in a positive balance of bone turnover as indicated by bone biomarkers. Further studies are needed to evaluate the potential beneficial effects of JAK inhibitors on inflammatory bone loss.
23
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra, Marina Stolina, Karin Polzer et al. · Nature Medicine · 2007 · 1.3K citations
Musculoskeletal Research, Molecular Biology, Master Regulator +1
Generalised bone loss in patients with early rheumatoid arthritis
Andrew Gough · The Lancet · 1994 · 635 citations
Klaus Engelke, Judith E. Adams, Gabriele Armbrecht et al. · Journal of Clinical Densitometry · 2008 · 597 citations